Charles W. Newhall III - 16 Nov 2023 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
Director
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Issuer symbol
SUPN
Transactions as of
16 Nov 2023
Net transactions value
-$1,122
Form type
4
Filing time
20 Nov 2023, 17:00:07 UTC
Previous filing
27 Feb 2023
Next filing
26 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SUPN Common Stock Options Exercise $68,903 +7,457 +6.7% $9.24 119,589 16 Nov 2023 Direct
transaction SUPN Common Stock Sale $70,025 -2,500 -2.1% $28.01 117,089 16 Nov 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Director Stock Option (Right to Buy) Options Exercise $0 -7,457 -100% $0.000000* 0 16 Nov 2023 Common Stock 7,457 $9.24 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of common stock sold to cover the exercise price of the employee stock options.